The BCG replacement vaccine VPM1002: from drawing board to clinical trial
The BCG replacement vaccine VPM1002: from drawing board to clinical trial
About this item
Full title
Author / Creator
Publisher
England: Informa UK, Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Informa UK, Ltd
Subjects
More information
Scope and Contents
Contents
Tuberculosis remains a major health threat and vaccines better than bacillus Calmette-Guérin (BCG) are urgently required. Here we describe our experience with a recombinant BCG expressing listeriolysin and deficient in urease. This potential replacement vaccine has demonstrated superior efficacy and safety over BCG in Mycobacterium tuberculosis aer...
Alternative Titles
Full title
The BCG replacement vaccine VPM1002: from drawing board to clinical trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_informahealthcare_journals_10_1586_14760584_2014_905746
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_informahealthcare_journals_10_1586_14760584_2014_905746
Other Identifiers
ISSN
1476-0584
E-ISSN
1744-8395
DOI
10.1586/14760584.2014.905746
